Next Article in Journal
Economic Impacts of Initiating Vaccination at 3 Months vs. 6 Months in an Influenza Pandemic in the United States
Next Article in Special Issue
IgG Antibodies to Pneumococcal Serotypes 1 and 5 in Relation to PCV13 Vaccination Status in Children Aged Under 5 Years in Lao PDR: A Cross-Sectional Survey
Previous Article in Journal
Correction: Huang et al. The Safety and Immunogenicity of a Quadrivalent Influenza Subunit Vaccine in Healthy Children Aged 6–35 Months: A Randomized, Blinded and Positive-Controlled Phase III Clinical Trial. Vaccines 2025, 13, 467
 
 
Article

Article Versions Notes

Vaccines 2025, 13(8), 827; https://doi.org/10.3390/vaccines13080827
Action Date Notes Link
article xml file uploaded 1 August 2025 13:54 CEST Original file -
article xml uploaded. 1 August 2025 13:54 CEST Update -
article pdf uploaded. 1 August 2025 13:54 CEST Version of Record https://www.mdpi.com/2076-393X/13/8/827/pdf-vor
article supplementary file uploaded. 1 August 2025 13:54 CEST - https://www.mdpi.com/2076-393X/13/8/827#supplementary
article html file updated 1 August 2025 13:55 CEST Original file -
article xml file uploaded 4 August 2025 10:31 CEST Update -
article xml uploaded. 4 August 2025 10:31 CEST Update https://www.mdpi.com/2076-393X/13/8/827/xml
article pdf uploaded. 4 August 2025 10:31 CEST Updated version of record https://www.mdpi.com/2076-393X/13/8/827/pdf
article html file updated 4 August 2025 10:33 CEST Update https://www.mdpi.com/2076-393X/13/8/827/html
Back to TopTop